AC
SBBP

Armistice Capital’s Strongbridge Biopharma plc. SBBP Stock Holding History

Armistice Capital’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,580,000
Closed -$4.95M – 87
2019
Q2 		$4.95M Sell
1,580,000
-912,000
-37% -$3.35M 0.31% 49
2019
Q1 		$12.4M Sell
2,492,000
-386,000
-13% -$1.9M 0.68% 36
2018
Q4 		$12.9M Buy
2,878,000
+228,000
+9% +$1.11M 0.98% 25
2018
Q3 		$12.9M Buy
2,650,000
+492,000
+23% +$2.52M 0.77% 37
2018
Q2 		$12.9M Sell
2,158,000
-1,214,000
-36% -$8.88M 0.85% 38
2018
Q1 		$29.8M Buy
3,372,000
+502,000
+17% +$3.76M 2.28% 17
2017
Q4 		$20.8M Buy
2,870,000
+1,175,400
+69% +$7.34M 2.07% 15
2017
Q3 		$11.7M Buy
1,694,600
+2,600
+0.2% +$17.9K 1.38% 26
2017
Q2 		$12.1M Buy
1,692,000
+52,000
+3% +$240K 1.54% 23
2017
Q1 		$7.79M Buy
+1,640,000
New +$5.02M 1.61% 26

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital's SBBP Position: Q3 2019 in Review

Armistice Capital sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2019, closing a stake of 1,580,000 shares — an estimated $4.95M sold.

Armistice Capital first reported a position in SBBP in Q1 2017 and held it in 10 quarters. The position peaked at $29.8M in Q1 2018. 54 funds tracked by Wall St. Rank hold SBBP as of Q3 2019.

  • Armistice Capital reported no remaining Strongbridge Biopharma plc. position as of Q3 2019 after selling out during the quarter.
  • Armistice Capital sold 1,580,000 Strongbridge Biopharma plc. shares in Q3 2019, an estimated $4.95M.
  • Armistice Capital first reported a position in Strongbridge Biopharma plc. in Q1 2017 and held it in 10 quarters.
  • Armistice Capital's Strongbridge Biopharma plc. position peaked at $29.8M in Q1 2018.
  • 54 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2019.

Based on Armistice Capital's 13F filing for Q3 2019, filed 14 Nov 2019.